Department of emergency and critical care medicine, The Affiliated Suzhou Science&Technology Town Hospital of Nanjing Medical University, Suzhou, China.
Department of Respiratory Medicine, Gannan Medical University, Ganzhou, China.
Bioengineered. 2021 Dec;12(1):8336-8346. doi: 10.1080/21655979.2021.1985817.
The protein phosphatase 1 regulatory subunit 3 G (PPP1R3G) participates in many tumor biological processes; however, its effects on lung adenocarcinoma (LUAD) have not been clarified. Therefore, this study aimed to explore the correlation between PPP1R3G and the prognosis and immune invasion of LUAD. We evaluated the relationship between PPP1R3G and LUAD using a wide range of databases and analysis tools, including UALCAN, TIMER, miRDB, The Human Protein Atlas and the MethSurv database. First, we explored the mRNA and protein expression levels of PPP1R3G in LUAD, and results were validated using real-time PCR. Next, we explored the relationship between PPP1R3G expression and clinical features. Finally, Kaplan-Meier curves and Cox regression were employed to investigate the prognostic significance of PPP1R3G in LUAD. In addition, we explored the relationship between the expression of PPP1R3G and immune infiltration using the TIMER database. We analyzed the relationship between PPP1R3G and methylation using MethSurv database. Results showed that PPP1R3G expression in LUAD tissues was higher than that in normal tissues, and high expression was suggestive of a poor prognosis. Moreover, PPP1R3G expression was positively correlated with the immune infiltration of CD4 + T cells, macrophages, neutrophils, and dendritic cells. PPP1R3G copy number variations also demonstrated remarkable associations with the levels of B cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells. Finally, a PPP1R3G-associated regulatory network was constructed. Overall, PPP1R3G might be a poor prognostic biomarker for LUAD and is associated with tumor immune cell infiltration. LUAD: Lung adenocarcinoma; PPP1R3G: The protein phosphatase 1 regulatory subunit 3G; OS: overall survival; CI: confidence interval; CNV: copy number variance; HR: Hazard Ratio; ROC: receiver operating characteristic curve; AUC: area under the curve; TCGA: The Cancer Genome Atlas.
蛋白磷酸酶 1 调节亚基 3G(PPP1R3G)参与许多肿瘤的生物学过程;然而,其对肺腺癌(LUAD)的影响尚未阐明。因此,本研究旨在探讨 PPP1R3G 与 LUAD 的预后和免疫浸润的相关性。我们使用包括 UALCAN、TIMER、miRDB、The Human Protein Atlas 和 MethSurv 数据库在内的广泛数据库和分析工具来评估 PPP1R3G 与 LUAD 之间的关系。首先,我们使用实时 PCR 验证了 PPP1R3G 在 LUAD 中的 mRNA 和蛋白表达水平。接着,我们探讨了 PPP1R3G 表达与临床特征之间的关系。最后,采用 Kaplan-Meier 曲线和 Cox 回归分析 PPP1R3G 在 LUAD 中的预后意义。此外,我们使用 TIMER 数据库探讨了 PPP1R3G 表达与免疫浸润的关系。我们使用 MethSurv 数据库分析了 PPP1R3G 与甲基化的关系。结果显示,PPP1R3G 在 LUAD 组织中的表达高于正常组织,且高表达提示预后不良。此外,PPP1R3G 表达与 CD4+T 细胞、巨噬细胞、中性粒细胞和树突状细胞的免疫浸润呈正相关。PPP1R3G 拷贝数变异也与 B 细胞、CD4+T 细胞、巨噬细胞、中性粒细胞和树突状细胞的水平显著相关。最后,构建了一个 PPP1R3G 相关的调控网络。总的来说,PPP1R3G 可能是 LUAD 的一个不良预后生物标志物,与肿瘤免疫细胞浸润有关。